NewAmsterdam Pharma (NAMS) Prepaid Assets (2021 - 2026)

NewAmsterdam Pharma (NAMS) has 6 years of Prepaid Assets data on file, last reported at $20.6 million in Q1 2026.

• For the quarter ending Q1 2026, Prepaid Assets rose 494.6% year-over-year to $20.6 million; the trailing twelve-month figure through Mar 2026 stood at $20.6 million (up 494.6% YoY), and the FY2025 full-year result was $1.8 million, down 17.03% from the prior year.
• Prepaid Assets grew to $20.6 million in Q1 2026, from $1.8 million in the prior quarter.
• In the past five years, Prepaid Assets ranged from a high of $20.6 million in Q1 2026 to a low of $1.5 million in Q2 2025.
• A 5-year average of $6.6 million and a median of $2.8 million in 2024 frame the typical range for Prepaid Assets.
• Across the five-year window, Prepaid Assets sank 90.13% in 2025 and soared 494.6% in 2026, its largest moves.
• Tracing NAMS's Prepaid Assets over 5 years: stood at $7.8 million in 2022, then slumped by 72.87% to $2.1 million in 2023, then gained by 4.29% to $2.2 million in 2024, then declined by 17.03% to $1.8 million in 2025, then soared by 1021.56% to $20.6 million in 2026.
• Business Quant data shows NAMS's Prepaid Assets at $20.6 million in Q1 2026, $1.8 million in Q4 2025, and $1.5 million in Q3 2025.